1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
- Contribution to journal › Article
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
- Contribution to journal › Article
-
Mark
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum
- Contribution to journal › Article
-
Mark
Assessment of myocardial sympathetic innervation with [123I]mIBG myocardial scintigraphy : A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera
(2025) In Journal of Nuclear Cardiology
- Contribution to journal › Article
- 2024
-
Mark
Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study
- Contribution to journal › Article
-
Mark
Diffusion tensor imaging along the perivascular space : the bias from crossing fibres
- Contribution to journal › Article
- 2023
-
Mark
Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy
- Contribution to journal › Article
-
Mark
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
- Contribution to journal › Article
-
Mark
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
- Contribution to journal › Article
-
Mark
Clinical effects of Lewy body pathology in cognitively impaired individuals
- Contribution to journal › Article
